Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) plans to begin clinical trials of a Muse cell-based…...
Please subscribe to read the full story.
Life Science Institute
LSII Moves Toward Commercial Production of Muse Cells
Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) is embarking on commercial production of Muse cells, which…...
Please subscribe to read the full story.
Interview: Mitsubishi Chemical Holdings President Talks Recent Performance, Aims
The Chemical Daily recently sat down with Hitoshi Ochi, president and CEO of Mitsubishi Chemical Holdings Corp. (TYO:4188), to gain…...
Please subscribe to read the full story.
